About Us

Spektron Systems is dedicated to disrupting the pharmaceutical discovery industry, providing better, lower cost drugs to the market much faster than is possible via the present system. With our proprietary approach and our team of world class talent, Spektron is converting the ‘art’ and brute force ‘luck’ of conventional drug discovery to a firmly based engineering approach.

The Spektron Team

Great companies are built by great personalities – we are breaking the mold when it comes to our hiring techniques. We are people-centric and seek individuals who are passionate about our mission. We diligently worked to capture a group of highly trained professionals in several specialty areas not commonly seen in drug discovery.

We currently have seven full-time employees and sixteen contractors.

Ted Moskal, Founder, CEO, Principal Architect. He is a serial entrepreneur, having founded two prior life sciences companies. He has over 25 years of senior leadership experience in biotechnology product development, bio-instrumentation engineering, advanced software and numerical methods, regulatory approval, marketing, operations, fundraising, strategic alliance development and growth management. Mr. Moskal has been a key technical resource for the development of the Q-MAP program for the past nine years. He has a B.S. in Aerospace Engineering from Penn State University.

Dr. David Wolf, Founder, CMO, key scientific advisor. He is a licensed physician, astronaut, electrical engineer and life sciences, inventor/researcher. His experience includes leadership positions as Chief Engineer and Program Manager for NASA programs, board level program management responsibility and influence and oversight for multiple, national and international, endeavors within NASA. Dr. Wolf was the recipient of the NASA Inventor of the Year in 1992.  He has a B.S. in Electrical Engineering from Purdue University and an M.D. from Indiana University School of Medicine.

Dr. John Panos, Director, Technical Operations. His specialties include schizophrenia, Alzheimer’s disease, addiction, behavioral pharmacology, marine pharmacology, neuropharmacology, neurochemistry, and neurotoxicology. Dr. Panos has advanced experience from postdoctoral fellowships in the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine, in the Department of Psychiatry Division of Psychopharmacology at Vanderbilt University Medical Center and as an ORISE Fellow at the U.S. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) in the Division of Neurotoxicology.

Tim Dockins, Program Manager, Computational Modeling. He is a polyglot programmer with an emphasis on complex data manipulation and visualization. He has an extensive background in several specialty areas, including, predictive modeling, machine learning and pattern classification, scale-free and random networks, social networks, user interface design and implementation, data mining, manipulation, visualization and program management. Tim received a B.S. in Computer Science from the University of Texas at Arlington.

Bob D’Agostino, Director, Computational Programs.  Bob is responsible for leading the predictive modeling and machine learning efforts at Spektron.  His expertise is in machine learning, signal and image processing, software development, and project management.  Bob has over 15 years of experience leading/implementing scientific computing projects for a variety of industries and applications, including drug discovery, defense, chemical detection, semiconductors, and the automotive industry.  Bob has extensive experience leading software development projects and in implementing software quality assurance programs and best practices.  He has a B.S. in Physics from Syracuse University and an M.S. in Applied Mathematics from the University of Massachusetts Lowell.

Cara (CJ) Condray-Azhar, Corporate Communications Specialist ll. She serves as a conscience for the Company, ensuring the key constituencies (e.g. team members, investors, potential investors, key opinion leaders, “Big Pharma” and the public) receive transparent and professional communication from Spektron. Working closely with the team, she helps oversee communication strategy, media relations, crisis communication, internal communication, reputation management, corporate responsibility, Investor Relations, government relationships, Key Opinion Leader relationships and marketing communication. Cara has a B.S. in Strategic Communication from Arkansas State University.

Ashley Meyer, Bioinformatics Scientist.  She is responsible for the acquisition and curation of bioinformatics data for the predictive modeling efforts of Spektron. She served as an instructor of Microbiology and Human Anatomy and Physiology at the University of Louisiana at Monroe and Pulaski Technical College in Little Rock, AR. Her experience spans over several areas such as bacterial culturing, radio telemetry, transmitter and PIT tagging, and collection of morphometric data for invertebrates.  Ashley received a B.S. in Biology from the University of Arkansas at Little Rock and an M.S. in Biology, with an emphasis in Evolutionary Ecology, from the University of Louisiana at Monroe.